Risk Management

Practical recommendations to consider in advance of exploring a potential sale or partnership transaction

Health care practices need to navigate real estate challenges and focus on strategic location decisions and data-driven insights to ensure future growth and patient care efficiency.

From ghost patients and fake genetic tests to DME laundering rings and opioid pill mills, the DOJ’s 2025 health care fraud crackdown paints a sobering picture of a system under attack — and a federal response gaining traction.

As workplace violence rises, health care facilities must shift from retrofitted tech to frontline-first safety solutions

Explore the essentials of forming a medical practice partnership, including operating agreements, income distribution, and buy-in/buy-out strategies before signing a contract.

Medical malpractice insurance needs an update

A recent district court case shows an LLC might not be enough

The secrets of evaluation and management coding success.

Occurrence, claims-made and tail insurance explained.

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

How to safeguard the benefits of private practice.

Tariffs will likely result in rising costs and supply chain disruptions that will reshape the economic outlook for the global economy — and your business too.

Andrea Greco, SVP of health care safety at CENTEGIX, sat down with Medical Economics for an exclusive Q&A.

Andrea Greco, SVP of healthcare safety at CENTEGIX, discusses risk assessments in medical practices.

Andrea Greco, SVP of healthcare safety at CENTEGIX, details one key change to improve practice safety.

Andrea Greco, SVP of healthcare safety at CENTEGIX, details cost-effective options for smaller practices looking to conduct risk assessments.

Andrea Greco, SVP of healthcare safety at CENTEGIX, talks about possible next steps once risks are identified.

Andrea Greco, SVP of Healthcare Safety at CENTEGIX, breaks down the key legal and regulatory factors medical practices must consider when conducting risk assessments.

Andrea Greco, SVP of healthcare safety at CENTEGIX, identifies common shortcomings of risk assessments and explains how practices can address their blind spots.

Andrea Greco, SVP of healthcare safety at CENTEGIX, talks about common risk assessment tools.

Andrea Greco, SVP of healthcare safety at CENTEGIX, explains when medical practices should conduct risk assessments.

Andrea Greco, SVP of healthcare safety at CENTEGIX, explains why risk assessments are so important for medical practices.

Andrea Greco, SVP of healthcare safety at CENTEGIX, discusses risk assessments in medical practices.